Abstract:BackgroundThe tumor microenvironment contains chemokines that play a crucial role in various processes, such as tumorigenesis, inflammation, and therapy resistance, in different types of cancer. CXCL5 is a significant chemokine that has been shown to promote tumor proliferation, invasion, angiogenesis, and therapy resistance when overexpressed in various types of cancer. This research aims to investigate the impact of CXCL5 on the biological functions of glioblastoma (GBM).MethodsThe TCGA GBM and GEO databases were utilized to perform transcriptome microarray analysis and oncogenic signaling pathway analysis of CXCL5 in GBM. Validation of CXCL5 expression was performed using RT-qPCR and Western Blot. The impact of CXCL5 on cell proliferation, tumorigenesis, and angiogenesis in GBM was assessed through various methods, including cell proliferation assay, cloning assay, intracranial xenograft tumor models, and tube formation assay. Clinical prognosis was evaluated in 59 samples of gliomas with varying degrees of malignancy (grades 2, 3, and 4) and the TCGA GBM database, based on CXCL5 expression levels. The activities of the JAK-STAT and NF-& kappa;B signaling pathways were detected using Western Blot.ResultsThe expression of CXCL5 was highly enriched in GBM. Moreover, the inhibition of CXCL5 showed a significant efficacy in suppressing cellular proliferation and angiogenesis, resulting in extended survival rates in xenograft mouse models in comparison to the control group. Notably, pretreatment with dapsone exhibited a reversal of the impact of CXCL5 on the formation of colonies and tubes in GBM cells. Elevated expression of CXCL5 was correlated with poor outcomes in GBM patients. Furthermore, the overexpression of CXCL5 has been associated with the activation of JAK-STAT and NF-& kappa;B signaling pathways.ConclusionsCXCL5 plays an important role in tumorigenesis and angiogenesis, indicating the potential for novel therapies targeting CXCL5 in GBM.

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-b signaling pathways

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways

ZNF395 Facilitates Macrophage Polarization and Impacts the Prognosis of Glioma.

Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

Integrative Analysis Reveals the Potential Prognostic Roles and Immunological Values of Unc-5 Netrin Receptor A (UNC5A) in Glioma

Circular RNA XRCC5 aggravates glioma progression by activating CLC3/SGK1 axis via recruiting IGF2BP2

Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma

The Chemokine Cxcl12 and Its Receptor Cxcr4 Promote Glioma Stem Cell-Mediated Vegf Production and Tumour Angiogenesis Via Pi3k/Akt Signalling

Upregulation of Chemokine Receptor Ccr10 is Essential for Glioma Proliferation, Invasion and Patient Survival

Expression of CDC5L is associated with tumor progression in gliomas

Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.

Increased expression of homeobox 5 predicts poor prognosis: A potential therapeutic target for glioma

CircXRCC5, as a potential novel biomarker, promotes glioma progression via the miR-490-3p/XRCC5/CLC3 ceRNA network

HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-β/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma

CXCL5 Promotes Gastric Cancer Metastasis by Inducing Epithelial-Mesenchymal Transition and Activating Neutrophils

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

Distribution of CXCL12 and CXC chemokine receptor-4 in glioblastoma microenviroment and the role of them in invasion and migration

CCL2 activates AKT signaling to promote glycolysis and chemoresistance in glioma cells

Human Astrocytes Secrete Il-6 to Promote Glioma Migration and Invasion Through Upregulation of Cytomembrane Mmp14

Chemokine Receptor CXCR4 Interacts with Nuclear Receptor Nur77 and Promote Glioma Invasion and Progression.